DGX
Quest Diagnostics Incorporated
NYSE · Healthcare · Medical - Diagnostics & Research · US
$237.36
−0.85%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
20.7x
EV/EBITDA
16.1x
Market Cap
$26.20B
MomentumView details →
1D Return
−0.85%
YTD Return
+36.67%
RSI (14)
52.0
ValuationView details →
P/E (Fwd)
20.7x
EV/EBITDA
16.1x
Market Cap
$26.20B
RSI (14)
52.0
MomentumView details →
1D Return
−0.85%
YTD Return
+36.67%
SummaryUpdated Jun 1, 2026
Quest Diagnostics Incorporated (NYSE:DGX) is one of the largest clinical laboratory testing companies in the United States, founded in 1967 and headquartered in Secaucus, New Jersey. The company went public in 1996 and has grown through both organic expansion and strategic acquisitions to become a dominant player in the diagnostic testing industry. Quest operates a nationwide network of laboratories and patient service centers, providing essential diagnostic information services to healthcare providers, patients, and other stakeholders across the healthcare ecosystem.
Similar companies
Latest newsMore news →
Humanity Health Inc. launched its Humanity Biological Age analysis in the United States through Quest Diagnostics' consumer-initiated testing platform questhealth.com.10d agoWhoop announced that its Advanced Labs health screenings no longer require a subscription, and added the multi-cancer early detection test Galleri to its portfolio.17d ago